Fig. 5. A strong correlation between results from three different assays indicate minimal impact of prior bamlanivimab infusion on endogenous antibody response to full COVID-19 vaccination.

Correlation matrices showing the degree of correlation between paired results from ACE2-RBD binding inhibition assays, pseudovirus neutralization assays (spike-E484Q), and antibody titers (spike-RBD-E484Q). Correlation strength was determined for participants who received placebo (n=62) or bamlanivimab (n=73) using cor.test() function in R with asymptotic t approximation to calculate the Spearman correlation. ρ represents the Spearman correlation; p represents the p-value.